| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,588,676 |
|
|
|
Indirect Value
|
$4,891,842 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,480,518 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-03-10 |
4 |
AS |
$327.76 |
$8,719,378 |
D/D |
(26,124) |
28,265 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2020-04-14 |
4 |
A |
$29.56 |
$6,999,985 |
D/D |
236,806 |
4,713,559 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2020-04-14 |
4 |
D |
$29.56 |
$6,999,985 |
I/I |
(236,806) |
1,907,329 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4 |
D |
$392.11 |
$4,754,334 |
D/D |
(12,125) |
47,900 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-07-15 |
4 |
D |
$224.33 |
$4,489,068 |
D/D |
(20,011) |
50,239 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-07-16 |
4 |
AS |
$312.37 |
$3,847,149 |
D/D |
(12,316) |
22,496 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2016-12-05 |
4 |
S |
$17.81 |
$3,646,028 |
D/D |
(204,718) |
1,463,468 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-10 |
4 |
D |
$395.13 |
$3,505,198 |
D/D |
(8,871) |
34,277 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2016-12-05 |
4 |
OE |
$8.99 |
$3,218,204 |
D/D |
357,976 |
1,668,186 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-07-15 |
4 |
D |
$312.00 |
$3,139,344 |
D/D |
(10,062) |
34,812 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-12 |
4 |
D |
$247.22 |
$2,920,904 |
D/D |
(11,815) |
60,335 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-10 |
4 |
D |
$315.54 |
$2,801,995 |
D/D |
(8,880) |
55,417 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-23 |
4 |
AS |
$25.68 |
$2,598,635 |
D/D |
(100,000) |
753,031 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-16 |
4 |
D |
$144.61 |
$2,556,560 |
D/D |
(17,679) |
67,577 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-09 |
4 |
D |
$396.88 |
$1,960,587 |
D/D |
(4,940) |
24,315 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-05-18 |
4 |
AS |
$25.96 |
$1,947,000 |
D/D |
(75,000) |
714,717 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-09 |
4 |
D |
$315.54 |
$1,530,369 |
D/D |
(4,850) |
45,464 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-02-10 |
4 |
D |
$164.44 |
$1,461,872 |
D/D |
(8,890) |
56,901 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-12 |
4 |
D |
$323.04 |
$1,399,732 |
D/D |
(4,333) |
57,817 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-09 |
4 |
D |
$249.99 |
$1,326,197 |
D/D |
(5,305) |
47,059 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-20 |
4 |
AS |
$105.94 |
$1,315,033 |
D/D |
(12,347) |
54,457 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-20 |
4 |
AS |
$23.39 |
$1,194,637 |
D/D |
(50,000) |
863,031 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-02-18 |
4 |
AS |
$20.73 |
$1,036,500 |
D/D |
(50,000) |
963,031 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-03-03 |
4 |
AS |
$335.79 |
$987,894 |
D/D |
(2,942) |
54,389 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-05-31 |
4 |
AS |
$290.00 |
$976,720 |
D/D |
(3,368) |
56,265 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
